Select Cognition Coverage and Published Editorials
Assessing Investigational CT1812’s Impact on Tau, Amyloid, and Neurodegeneration
Neurology Live
By Marco Meglio
April 3, 2025
2025 Is Shaping Up to Be a Big Year for This Drug Maker Working to Cure Dementia
Benzinga All-Access
Host: Dan Leach
April 1, 2025
BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812
BioWorld
By Karen Carey
February 12, 2025
Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference
Benzinga
By Meg Flippin
February 5, 2025
Cognition Therapeutics is Targeting a Critical Form of Dementia
Benzinga All-Access
Host: Dan Leach
January 7, 2025
Oral Small Molecule Shows Promise in Dementia with Lewy Bodies
Healio
December 23, 2024
Connect with us on Social Media

